Prime Minister Boris Johnson said he will carefully follow the advice on the Oxford/AstraZeneca vaccine from the MHRA and JCVI but does not believe he will alter the schedule for easing the lockdown.
The benefits of the Oxford/AstraZeneca vaccine continue to outweigh any risks for most people, the UK medicines watchdog has said, as European regulators ruled that unusual blood clots were "very rare side effects" of the jab.
Receive newsletters with the latest news, sport and what's on updates from the Liverpool ECHO by signing up here.
A review by the European Medicines Agency's safety committee concluded on Wednesday that "unusual blood clots with low blood platelets should be listed as very rare side effects" of the Oxford/AstraZeneca vaccine.
In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said there were still huge benefits of the vaccine in preventing Covid-19 and serious disease.
However, due to a very small number of blood clots in younger people, those under the age of 30 will be offered Pfizer or Moderna instead.
Enter your postcode below to find the latest covid figures where you live:
During a visit to Cornwall, Mr Johnson told broadcasters: "I think the crucial thing on this is to listen to what the scientists, and the doctors, the medical experts, have to say.
"The MHRA is meeting, the JCVI is meeting, they'll be setting out the position and we will get on with rolling out the vaccine and obviously we'll follow very carefully what they have to say.
"I don't think anything that I have seen leads me to suppose that we will have to change the road map or deviate from the road map in any way."
